To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM)
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to GBM
Related studies linked through entity extraction aliases.
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
- Status
- TERMINATED
- Phase
- PHASE3
BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Integrative Analysis of Human Glioblastoma Multiforme
- Status
- RECRUITING
- Phase
- N/A
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
- Status
- COMPLETED
- Phase
- PHASE2
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 0 Study of AZD1775 in Recurrent GBM Patients
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
- Status
- AVAILABLE
- Phase
- N/A
BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE2